Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors

S Mulier, Y Ni, J Jamart, T Ruers, G Marchal… - Annals of …, 2005 - journals.lww.com
Objective: The purpose of this study was to analyze the factors that influence local
recurrence after radiofrequency coagulation of liver tumors. Summary Background Data …

Epidemiology and management of hepatocellular carcinoma

JD Yang, LR Roberts - Infectious Disease Clinics, 2010 - id.theclinics.com
Hepatocellular carcinoma (HCC) is the seventh most common cancer and the third leading
cause of cancer-related death worldwide, with an estimated 748,000 new liver cancer cases …

Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial

ZW Peng, YJ Zhang, MS Chen, L Xu… - Journal of clinical …, 2013 - ascopubs.org
Purpose To compare radiofrequency ablation (RFA) with or without transcatheter arterial
chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC). Patients …

Midterm outcomes in patients with intermediate‐sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation …

M Morimoto, K Numata, M Kondou, A Nozaki, S Morita… - Cancer, 2010 - Wiley Online Library
BACKGROUND: To improve the efficacy of radiofrequency ablation (RFA) for the treatment
of intermediate‐sized hepatocellular carcinomas (HCCs), the authors compared RFA …

Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone …

T Shibata, H Isoda, Y Hirokawa, S Arizono, K Shimada… - Radiology, 2009 - pubs.rsna.org
Purpose To prospectively compare combined radiofrequency ablation and transcatheter
arterial chemoembolization (TACE) with radiofrequency ablation alone for the treatment of …

Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma …

A Veltri, P Moretto, A Doriguzzi, E Pagano, G Carrara… - European …, 2006 - Springer
The treatment of unresectable “non-early”(according to the BCLC classification)
hepatocellular carcinoma (HCC) in cirrhotic patients with transcatheter arterial …

[PDF][PDF] Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy

DB Brown, B Nikolic, AM Covey, CW Nutting… - Journal of Vascular …, 2012 - academia.edu
The draft document is critically reviewed by the Standards of Practice Committee members
by telephone conference calling or face-to-face meeting. The finalized draft from the …

Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications

TJ Vogl, NNN Naguib, NEA Nour-Eldin, P Rao… - European journal of …, 2009 - Elsevier
The current review provides an overview on the palliative, combined, neoadjuvant, bridging,
and symptomatic indications of transarterial chemoembolization (TACE) in patients with …

Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution

RT Poon, KK Ng, CM Lam, V Ai, J Yuen, ST Fan… - Annals of …, 2004 - journals.lww.com
Objective: This study aims to evaluate the effect of operator experience on the treatment
outcomes of radiofrequency ablation (RFA) for malignant liver tumors. Summary Background …

Early-Stage Hepatocellular Carcinoma: Radiofrequency Ablation Combined with Chemoembolization versus Hepatectomy1

K Yamakado, A Nakatsuka, H Takaki, H Yokoi, M Usui… - Radiology, 2008 - pubs.rsna.org
Purpose: To retrospectively evaluate the long-term results of radiofrequency (RF) ablation
combined with chemoembolization (combination therapy) as compared with hepatectomy for …